GSK Pursues Futura Medical's OTC Topical NSAID Under Development
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline's relationship with Futura Medical is on again as the pharmaceutical giant agrees to fund development of Futura's novel topical pain reliever TPR100